These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 8393471)

  • 1. Cardiac allograft vasculopathy: current concepts.
    Ventura HO; Smart FW; Stapleton DD; Toups T; Price HL
    J La State Med Soc; 1993 May; 145(5):195-8, 200-2. PubMed ID: 8393471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiac allograft vasculopathy: current concepts.
    Ventura HO; Mehra MR; Smart FW; Stapleton DD
    Am Heart J; 1995 Apr; 129(4):791-9. PubMed ID: 7900633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New developments in the diagnosis and management of cardiac allograft vasculopathy.
    Mehra MR; Ventura HO; Smart FW; Stapleton DD; Collins TJ; Ramee SR; Murgo JP; White CJ
    Tex Heart Inst J; 1995; 22(2):138-44. PubMed ID: 7647597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Experimental cardiac allograft vasculopathy in mice.
    Ardehali A; Billingsley A; Laks H; Drinkwater DC; Sorensen TJ; Drake TA
    J Heart Lung Transplant; 1993; 12(5):730-5. PubMed ID: 8241210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiac allograft vasculopathy: current concepts, recent developments, and future directions.
    Hosenpud JD; Shipley GD; Wagner CR
    J Heart Lung Transplant; 1992; 11(1 Pt 1):9-23. PubMed ID: 1540617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiac allograft vasculopathy: advances in diagnosis.
    Cai Q; Rangasetty UC; Barbagelata A; Fujise K; Koerner MM
    Cardiol Rev; 2011; 19(1):30-5. PubMed ID: 21135600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytomegalovirus infection and accelerated cardiac allograft vasculopathy in human cardiac allografts.
    Koskinen PK; Nieminen MS; Krogerus LA; Lemström KB; Mattila SP; Häyry PJ; Lautenschlager IT
    J Heart Lung Transplant; 1993; 12(5):724-9. PubMed ID: 8241209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allograft vasculopathy versus atherosclerosis.
    Rahmani M; Cruz RP; Granville DJ; McManus BM
    Circ Res; 2006 Oct; 99(8):801-15. PubMed ID: 17038650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiac allograft vasculopathy: a review.
    Ramzy D; Rao V; Brahm J; Miriuka S; Delgado D; Ross HJ
    Can J Surg; 2005 Aug; 48(4):319-27. PubMed ID: 16149368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiac allograft vasculopathy: pathology, prevention and treatment.
    Kass M; Haddad H
    Curr Opin Cardiol; 2006 Mar; 21(2):132-7. PubMed ID: 16470150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prognostic impact of immunosuppression and cellular rejection on cardiac allograft vasculopathy: time for a reappraisal.
    Mehra MR; Ventura HO; Chambers RB; Ramireddy K; Smart FW; Stapleton DD
    J Heart Lung Transplant; 1997 Jul; 16(7):743-51. PubMed ID: 9257256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Injury of the coronary endothelium at implantation increases endothelial dysfunction and intimal hyperplasia after heart transplantation.
    El-Hamamsy I; Stevens LM; Vanhoutte PM; Perrault LP
    J Heart Lung Transplant; 2005 Mar; 24(3):251-8. PubMed ID: 15737750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiac allograft vasculopathy: current knowledge and future direction.
    Colvin-Adams M; Agnihotri A
    Clin Transplant; 2011; 25(2):175-84. PubMed ID: 21457328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T-cell immunity to subclinical cytomegalovirus infection reduces cardiac allograft disease.
    Tu W; Potena L; Stepick-Biek P; Liu L; Dionis KY; Luikart H; Fearon WF; Holmes TH; Chin C; Cooke JP; Valantine HA; Mocarski ES; Lewis DB
    Circulation; 2006 Oct; 114(15):1608-15. PubMed ID: 17015794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular abnormalities and cardiomyocyte lipofuscin deposits in endomyocardial biopsy specimens of heart transplant recipients: are they related to the development of cardiac allograft vasculopathy?
    Zakliczynski M; Nozynski J; Konecka-Mrowka D; Krynicka-Mazurek A; Swierad M; Maruszewski M; Przybylski R; Zembala M
    J Thorac Cardiovasc Surg; 2009 Jul; 138(1):215-21, 221.e1-3. PubMed ID: 19577082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiac allograft vasculopathy.
    Lee MS; Finch W; Weisz G; Kirtane AJ
    Rev Cardiovasc Med; 2011; 12(3):143-52. PubMed ID: 22080925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term results of angioplasty vs stenting in cardiac transplant recipients with allograft vasculopathy.
    Simpson L; Lee EK; Hott BJ; Vega DJ; Book WM
    J Heart Lung Transplant; 2005 Sep; 24(9):1211-7. PubMed ID: 16143235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-dose cyclosporine treatment fails to prevent coronary luminal narrowing after heart transplantation.
    Vassalli G; Kaski JC; Tousoulis D; Kiowski W; Turina M; Follath F; Gallino A
    J Heart Lung Transplant; 1996 Jun; 15(6):612-9. PubMed ID: 8794036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neointimal smooth muscle cells in human cardiac allograft coronary artery vasculopathy are of donor origin.
    Atkinson C; Horsley J; Rhind-Tutt S; Charman S; Phillpotts CJ; Wallwork J; Goddard MJ
    J Heart Lung Transplant; 2004 Apr; 23(4):427-35. PubMed ID: 15063402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictive model to assess risk for cardiac allograft vasculopathy: an intravascular ultrasound study.
    Mehra MR; Ventura HO; Chambers R; Collins TJ; Ramee SR; Kates MA; Smart FW; Stapleton DD
    J Am Coll Cardiol; 1995 Nov; 26(6):1537-44. PubMed ID: 7594082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.